Literature DB >> 11792319

DREAM is a critical transcriptional repressor for pain modulation.

Hai-Ying M Cheng1, Graham M Pitcher, Steven R Laviolette, Ian Q Whishaw, Kit I Tong, Lisa K Kockeritz, Teiji Wada, Nicholas A Joza, Michael Crackower, Jason Goncalves, Ildiko Sarosi, James R Woodgett, Antonio J Oliveira-dos-Santos, Mitsuhiko Ikura, Derek van der Kooy, Michael W Salter, Josef M Penninger.   

Abstract

Control and treatment of chronic pain remain major clinical challenges. Progress may be facilitated by a greater understanding of the mechanisms underlying pain processing. Here we show that the calcium-sensing protein DREAM is a transcriptional repressor involved in modulating pain. dream(-/-) mice displayed markedly reduced responses in models of acute thermal, mechanical, and visceral pain. dream(-/-) mice also exhibited reduced pain behaviors in models of chronic neuropathic and inflammatory pain. However, dream(-/-) mice showed no major defects in motor function or learning and memory. Mice lacking DREAM had elevated levels of prodynorphin mRNA and dynorphin A peptides in the spinal cord, and the reduction of pain behaviors in dream(-/-) mice was mediated through dynorphin-selective kappa (kappa)-opiate receptors. Thus, DREAM appears to be a critical transcriptional repressor in pain processing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792319     DOI: 10.1016/s0092-8674(01)00629-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  97 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Increases in mRNA and DREAM protein expression in the rat spinal cord after formalin induced pain.

Authors:  Idris Long; Rapeah Suppian; Zalina Ismail
Journal:  Neurochem Res       Date:  2010-12-25       Impact factor: 3.996

Review 3.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

4.  Genetic polymorphism and protein conformational plasticity in the calmodulin superfamily: two ways to promote multifunctionality.

Authors:  Mitsuhiko Ikura; James B Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 5.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

Review 6.  [Peripheral mechanisms of joint pain with special focus on the synovial fibroblast].

Authors:  H Sprott
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

7.  KChIP3 coupled to Ca2+ oscillations exerts a tonic brake on baseline mucin release in the colon.

Authors:  Gerard Cantero-Recasens; Cristian M Butnaru; Miguel A Valverde; José R Naranjo; Nathalie Brouwers; Vivek Malhotra
Journal:  Elife       Date:  2018-10-01       Impact factor: 8.140

8.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19

9.  Neuronal calcium sensor-1 (Ncs1p) is up-regulated by calcineurin to promote Ca2+ tolerance in fission yeast.

Authors:  Nobuko Hamasaki-Katagiri; James B Ames
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

10.  The auxiliary subunit KChIP2 is an essential regulator of homeostatic excitability.

Authors:  Hong-Gang Wang; Xiao Ping He; Qiang Li; Roger D Madison; Scott D Moore; James O McNamara; Geoffrey S Pitt
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.